|
antiviral |
8 |
|
hbv |
8 |
|
kidney transplantation |
8 |
|
nephrotoxicity |
8 |
|
nucleoside analogues |
8 |
|
tenofovir |
8 |
|
dialysis |
7 |
|
proteinuria |
7 |
|
hepatitis b |
6 |
|
humans |
6 |
|
lupus nephritis |
6 |
|
male |
6 |
|
middle aged |
6 |
|
renal failure |
6 |
|
chronic kidney disease |
5 |
|
estimated glomerular filtration rate |
5 |
|
medical sciences |
5 |
|
outcome |
5 |
|
outcomes |
5 |
|
pathogenesis |
5 |
|
peritoneal dialysis |
5 |
|
peritonitis |
5 |
|
renal dysfunction |
5 |
|
systemic lupus erythematosus |
5 |
|
treatment |
5 |
|
urology and nephrology |
5 |
|
valvular heart disease |
5 |
|
adenine - analogs and derivatives - therapeutic use |
4 |
|
adult |
4 |
|
antiviral agents - adverse effects - therapeutic use |
4 |
|
biopsy |
4 |
|
end stage renal disease |
4 |
|
entecavir |
4 |
|
female |
4 |
|
fever - etiology |
4 |
|
hepatitis b, chronic - complications - diagnosis - drug therapy - mortality |
4 |
|
kidney diseases - complications - surgery |
4 |
|
kidney failure, chronic - therapy |
4 |
|
kidney neoplasms - pathology |
4 |
|
kidney transplantation - adverse effects - mortality |
4 |
|
lamivudine |
4 |
|
long-term |
4 |
|
lymphoma - pathology |
4 |
|
malnutrition - etiology |
4 |
|
proteinuria - etiology |
4 |
|
renal dialysis - adverse effects |
4 |
|
resistance |
4 |
|
superior mesenteric artery syndrome |
4 |
|
superior mesenteric artery syndrome - etiology - radiography - therapy |
4 |
|
vascular neoplasms - pathology |
4 |
|
acute kidney injury |
3 |
|
adenine - analogs & derivatives - pharmacology - therapeutic use |
3 |
|
aki |
3 |
|
alanine transaminase - blood |
3 |
|
antiviral agents - therapeutic use |
3 |
|
apolipoprotein e |
3 |
|
chronic allograft nephropathy |
3 |
|
commencement |
3 |
|
covid-19 |
3 |
|
creatinine - metabolism |
3 |
|
direct renin inhibitor |
3 |
|
dna, viral - analysis |
3 |
|
dose-response relationship, drug |
3 |
|
drug resistance, viral |
3 |
|
epidemiology |
3 |
|
guanine - analogs & derivatives - pharmacology - therapeutic use |
3 |
|
hepatitis b - complications - drug therapy |
3 |
|
hyponatremia |
3 |
|
iga nephropathy |
3 |
|
immunoglobulins |
3 |
|
kidney |
3 |
|
kidney - drug effects |
3 |
|
lamivudine - therapeutic use |
3 |
|
lamivudine resistance |
3 |
|
lipoprotein glomerulopathy |
3 |
|
minimal change disease |
3 |
|
mycophenolate |
3 |
|
nephropathy |
3 |
|
nephrotic syndrome |
3 |
|
phosphonic acids - pharmacology - therapeutic use |
3 |
|
plasma renin activity |
3 |
|
proximal renal tubular epithelial cells |
3 |
|
psychological symptoms |
3 |
|
renal allograft recipient |
3 |
|
serum cytokines |
3 |
|
shear wave elastography |
3 |
|
sle |
3 |
|
sleep apnea |
3 |
|
sodium |
3 |
|
statin |
3 |
|
transplantation |
3 |
|
ultrasound |
3 |
|
viral load - drug effects |
3 |
|
advanced ckd |
2 |
|
aged |
2 |
|
anaemia |
2 |
|
asymptomatic |
2 |
|
b cell abnormalities |
2 |
|
biopsy, needle |
2 |
|
blys |
2 |
|
childhood-onset |
2 |
|
chinese |
2 |
|
corticosteroids |
2 |
|
cyclophosphamide |
2 |
|
darbepoetin alpha |
2 |
|
diltiazem |
2 |
|
emphysema - microbiology - radiography |
2 |
|
epstein syndrome |
2 |
|
erythropoiesis-stimulating agent |
2 |
|
hearing loss, sensorineural - diagnosis - genetics |
2 |
|
hepatitis b virus |
2 |
|
hernia, abdominal - diagnosis - etiology - therapy |
2 |
|
hydralazine |
2 |
|
ifn |
2 |
|
il-17 |
2 |
|
il-18 |
2 |
|
il-6 |
2 |
|
immunology |
2 |
|
immunosuppression |
2 |
|
kidney - microbiology - radiography |
2 |
|
kidney transplantation - adverse effects |
2 |
|
kidney transplantation - methods |
2 |
|
klebsiella infections - radiography |
2 |
|
klebsiella pneumoniae |
2 |
|
longterm treatment |
2 |
|
lymphocele - diagnosis - etiology - therapy |
2 |
|
malignancy |
2 |
|
methoxy polyethylene glycol-epoetin beta |
2 |
|
mortality |
2 |
|
mycophenolate mofetil |
2 |
|
myosin heavy chains - genetics |
2 |
|
pain |
2 |
|
preemptive treatment |
2 |
|
pyelonephritis - microbiology - radiography |
2 |
|
renal insufficiency - diagnosis - genetics - surgery |
2 |
|
renal transplant |
2 |
|
serological reactivation |
2 |
|
sirolimus |
2 |
|
stents |
2 |
|
stevens-johnson syndrome |
2 |
|
symptom |
2 |
|
tacrolimus |
2 |
|
telbivudine |
2 |
|
thrombocytopenia |
2 |
|
thrombocytopenia - diagnosis - genetics |
2 |
|
thrombotic microangiopathy |
2 |
|
tnf |
2 |
|
tomography, x-ray computed |
2 |
|
toxic epidermal necrolysis |
2 |
|
anti-cd20 |
1 |
|
baff |
1 |
|
belimumab |
1 |
|
calcineurin |
1 |
|
charlson co-morbidity index |
1 |
|
childhood-onset lupus nephritis |
1 |
|
diagnosis |
1 |
|
exit site infection |
1 |
|
fall |
1 |
|
fracture |
1 |
|
lupus |
1 |
|
malnutrition |
1 |
|
management |
1 |
|
nephritis |
1 |
|
novel |
1 |
|
prophylaxis |
1 |
|
refractory |
1 |
|
rituximab |
1 |
|
umbilical abscess |
1 |
